Image

Global Psychedelic Drugs Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Published Report
  • Jun 2022
  • Global
  • 350 Pages
  • No of Tables: 294
  • No of Figures: 81

Global Psychedelic Drugs Market, By Source (Synthetic & Natural), Type (Empathogens, Dissociatives & Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Others), Route of Administration (Oral, Inhalation, Injectable), End User (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy) Industry Trends and Forecast to 2029

 

Psychedelic Drugs Market

Global Psychedelic Drugs Market Analysis and Insights

Psychedelic drugs involve various types of chemical substances including lysergic acid diethylamide (LSD) and chemical extracted from plants. These drugs have the ability to change or enhance the sensory perceptions, thought processes, energy levels and have also been reported to facilitate spiritual experiences.

Psychedelic Drugs Market

The psychedelic drugs can be categorized into empathogens and dissociative drugs (such as phenylcyclohexyl piperidine (PCP)) and serotonergic (classic hallucinogens) such as LSD. Both types of psychedelic drugs can cause hallucinations and feeling of sensation, moreover, dissociative drugs can make a person to fell out of control from their body or environment and make them feel disconnected. Based on the source, psychedelic drugs have been categorized under natural and synthetic types.

These drugs have wide applications in the treatment of major depressive disorder, post-traumatic stress disorder, panic disorder, treatment-resistant depression and opiate addiction among others. Psychedelic drugs are also known by several other names such as lysergic acid derivative (LSD) which are also known as blotter, dots, sugar, acid, trips and window pane, ketamine are also known as vitamin K, bump, green, K/special K, purple and super acid, PCP are also known as angel/angel dust, boat/love boat, peace, killer weed, super grass and ozone.

Global psychedelic drugs market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 13.3% in the forecast period of 2022 to 2029 and is expected to reach USD 6,401.95 million by 2029 from USD 2,386.72 million in 2021.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019-2014)

Quantitative Units

Revenue in USD Million, Pricing in USD

Segments Covered

By Source (Synthetic & Natural), Type (Empathogens, Dissociatives & Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Others), Route of Administration (Oral, Inhalation, Injectable), End User (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy)

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Belgium, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, India, South Korea, Australia, Singapore, Malaysia, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa

Market Players Covered

The major companies which are dealing in the market are Jazz Pharmaceuticals, Inc., Janssen Global Services, LLC (a subsidiary of Johnson & Johnson Services, Inc.), Hikma Pharmaceuticals PLC, COMPASS, Verrian, Pfizer Inc., F. Hoffmann-La Roche Ltd, Avadel, Celon Pharma SA., Cybin Corp., GH Research, Entheon Biomedical Corp, PharmaTher Holdings Ltd., NRx Pharmaceuticals, Inc., usonainstitute.org, among others.

Market Definition

Psychedelic drugs involve various types of chemical substances including lysergic acid diethylamide (LSD) and chemical extracted from plants. These drugs have the ability to change or enhance the sensory perceptions, thought processes, energy levels and have also been reported to facilitate spiritual experiences.

The psychedelic drugs can be categorized into empathogens and dissociative drugs (such as phenylcyclohexyl piperidine (PCP)) and serotonergic (classic hallucinogens) such as LSD. Both types of psychedelic drugs can cause hallucinations and feeling of sensation, moreover, dissociative drugs can make a person to fell out of control from their body or environment and makes them feel disconnected. Based on the source, psychedelic drugs have been categorized under natural and synthetic types.

These drugs have wide applications in the treatment of major depressive disorder, post-traumatic stress disorder, panic disorder, treatment-resistant depression and opiate addiction among others. Psychedelic drugs are also known by several other names such as lysergic acid derivative (LSD) which are also known as blotter, dots, sugar, acid, trips and window pane, ketamine are also known as vitamin K, bump, green, K/special K, purple and super acid, PCP are also known as angel/angel dust, boat/love boat, peace, killer weed, super grass and ozone.

Psychedelic Drugs Market Dynamics

Drivers

  • Growing Acceptance Of Psychedelic Drugs For Treating Depression

Psychedelics have achieved a large popularity within the last decade as they are involved with human mental healing and treatment practices and have the power of mind-healing. The growing researchers and scientist are exploring psychedelic drugs therapeutic value and compounds which could be a new treatment option for people with depression. Continuous research and development in the psychedelic drugs have increased the acceptance of psychedelics medication. Psychedelic drugs promising outcomes have increased the usage of psychedelic drugs across the U.S. and other regions which leads to rising demand for psychedelic drugs, hence these factors are expected to act as drivers for the growth of the market.

  • Increasing Prevalence Of Depression And Mental Disorders

Mental disorders (or mental illnesses) affects persons feeling, mood, thinking, and behaviour and can be long-lasting (chronic) or occasional. Depression and mental disorders have the ability to affect individual’s capacity by virtue of which they perform their everyday tasks. There are numerous dissimilar types of mental disorders. Depression and mental disorders have increased globally due to various factors including family history and genes, abuse or stress, biological factors, usage of alcohol or recreational drugs and many others.

Additionally, increasing consumption of illicit substances has increased depression and mental disorders. Thus, increasing prevalence of depression and mental disorders are increasing the demand for psychedelic drugs which is expected to act as driver for the growth of the market.

  • Rising Awareness Towards Mental Health

As mental illness has adversely impacted the people’s ability to carry out normal functions of their life, this has become important to create awareness among people regarding the different types of cause, disorders it leads to and the treatment options available in the market in order to cure such life-devastating illness. In order to raise awareness several organizations and companies are launching campaigns and adoption initiatives. This in turn allows patients to opt for effective treatment option as per the disease cause and reported symptoms. Advertisements, awareness campaigns, and others have increased the awareness for psychedelic drugs. The awareness campaigns have encouraged people to select appropriate treatment for mental disorders procedures which is increasing the demand of psychedelic drugs. For this reason, rising awareness towards mental health is expected to act as driver for the market growth.

Psychedelic Drugs Market

Opportunity

  • Increasing R&D Activities In Psychedelic Drugs

Psychedelic plants and fungi have been used in indigenous medicinal traditions for millennia. New psychedelic drugs development research has initiated by Albert Hofmann in 1938. He has synthesized the first lysergic acid diethylamide (LSD-25) and now recognized as the first person to ingest LSD after five years later. Hofmann was unaware of the significant effects and actions posed by that product. After a growing period of cultural and scientific exploration in the 1950s and 60s, psychedelic drug development research was slackened to a near halt. Increasing research and development expenditure in the psychedelic drugs is creating new opportunities in the market. Thus, increasing R&D activities in psychedelic drugs is acting as an opportunity for the growth of the market.

Also, the strategic initiatives taken by key market players will provide structural integrity and future opportunities for the psychedelic drugs market in the forecast period of 2022-2029.

Restraint/Challenge

  • High Cost Of Psychedelic Drugs

However, the high cost associated with psychedelic drugs will impede the growth rate of psychedelic drugs market. Additionally, stringent rules and regulations will further challenge the market in the forecast period mentioned above.

This psychedelic drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more information on psychedelic drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post COVID-19 Impact on psychedelic drugs market

The COVID-19 has positively affected the market. Lockdowns and isolation during pandemics complicate the disease management and medication adherence. Hence, the use of various treatment drugs has widely increased in the world’s population. Hence, the pandemic has effected positively on this market.

Recent Developments

  • In August 2020, Janssen Pharmaceuticals, Inc. received approval for its Spravato nasal spray indicated for treatment of suicidal people. As approximately 11% to 12% of Americans suffers from major depressive disorder that led them to commit suicide, this approval provided these patients with a remarkable therapy and paved the way for the company to generate more revenue.

•   In January 2020, Jazz Pharmaceuticals, Inc. has received the marketing authorization of solriamfetol (Sunosi) indicated for treatment of excessive daytime sleepiness in adults with narcolepsy. This authorization allowed the company to enhance product distribution network and to generate more revenue in the market

Global Psychedelic Drugs Market Scope

Global Psychedelic drugs market is segmented into the source, type, drugs, application, route of administration, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Source

  • Synthetic
  • Natural

On the basis of source, the global psychedelic drugs market is segmented into synthetic and natural.

Type

  • Empathogens
  • Dissociatives
  • Others

On the basis of type, the global psychedelic drugs market is segmented into empathogens, dissociatives, and others.

Drugs

  • Gamma-Hydroxybutyric Acid
  • Ketamine
  • Psilocybin
  • Others

On the basis of drugs, the global psychedelic drugs market is segmented into gamma-hydroxybutyric acid, ketamine, psilocybin and others.

Application

  • Narcolepsy,
  • Treatment Resistant Depression
  • Major Depressive Disorder
  • Opiate Addiction
  • Post-Traumatic Stress Disorder
  • Others

On the basis of application, the global psychedelic drugs market is segmented into narcolepsy, treatment resistant depression, major depressive disorder, opiate addiction, post-traumatic stress disorder and others.

Route of Administration

  • Oral
  • Inhalation
  • Injectable

On the basis of route of administration, the global psychedelic drugs market is segmented into oral, inhalation and injectable.

End User

  • Hospital
  • Speciality Clinics
  • Homecare
  • Others

On the basis of end user, the global psychedelic drugs market is segmented into hospital, speciality clinics, homecare, and others.

Distribution Channel

  • Hospitals Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Psychedelic Drugs Market

On the basis of distribution channel, the global psychedelic drugs market is segmented into hospitals pharmacy, retail pharmacy and online pharmacy.

Psychedelic Drugs Market Regional Analysis/Insights            

The psychedelic drugs market is analysed and market size insights and trends are provided by country, source, type, drugs, application, route of administration, end user and distribution channel as referenced above.

North America dominates the psychedelic drugs market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to high prevalence of mental disorders in the region and rapid research development is boosting the market

Psychedelic Drugs Market

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Psychedelic Drugs Market Share Analysis

The psychedelic drugs market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on psychedelic drugs market.

Some of the major players operating in the psychedelic drugs market are Jazz Pharmaceuticals, Inc., Janssen Global Services, LLC (a subsidiary of Johnson & Johnson Services, Inc.), Hikma Pharmaceuticals PLC, COMPASS, Verrian, Pfizer Inc., F. Hoffmann-La Roche Ltd, Avadel, Celon Pharma SA., Cybin Corp., GH Research, Entheon Biomedical Corp, PharmaTher Holdings Ltd., NRx Pharmaceuticals, Inc., usonainstitute.org, among others.

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analysed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs. Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report


SKU-

TABLE 1 GLOBAL PSYCHEDELIC DRUGS MARKET, PIPELINE ANALYSIS

TABLE 2 PSYCHEDELICS RESEARCH STUDIES, IN EUROPE

TABLE 3 MENTAL ILLNESS IN THE U.S. ADULTS, IN 2020

TABLE 4 MENTAL DISORDERS, IN THE U.S. ADULTS, IN 2020

TABLE 5 DRUG DEVELOPMENT PATHWAY FOR FDA APPROVAL OF NEW MEDICATIONS

TABLE 6 THE 1971 UN CONVENTION ON PSYCHOTROPIC SUBSTANCES

TABLE 7 MAGIC MUSHROOMS PRICES FOR RESEARCHERS, IN THE U.S.

TABLE 8 COST OF PSYCHEDELIC DRUGS

TABLE 9 PSYCHEDELIC DRUGS R&D ACTIVITIES

TABLE 10 GLOBAL PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 11 GLOBAL EMPATHOGENS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 GLOBAL DISSOCIATIVES IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 13 GLOBAL OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 GLOBAL PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 15 GLOBAL SYNTHETIC IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 GLOBAL NATURAL IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 GLOBAL PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 18 GLOBAL GAMMA-HYDROXYBUTYRIC ACID IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 GLOBAL KETAMINE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 GLOBAL PSILOCYBIN IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 GLOBAL OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 GLOBAL PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 23 GLOBAL NARCOLEPSY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 GLOBAL TREATMENT RESISTANT DEPRESSION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 GLOBAL MAJOR DEPRESSIVE DISORDER IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 GLOBAL OPIATE ADDICTION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 GLOBAL POST-TRAUMATIC STRESS DISORDER IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 GLOBAL OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 GLOBAL PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 30 GLOBAL ORAL IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 GLOBAL INHALATION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 GLOBAL INJECTABLE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 GLOBAL PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 34 GLOBAL HOSPITALS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 GLOBAL SPECIALTY CLINICS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 GLOBAL HOMECARE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 GLOBAL OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 38 GLOBAL PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 39 GLOBAL HOSPITALS PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 GLOBAL RETAIL PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 GLOBAL ONLINE PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 42 GLOBAL PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 43 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 44 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 45 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 46 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 47 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 48 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 49 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 50 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 51 U.S. PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 52 U.S. PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 53 U.S. PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 54 U.S. PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 55 U.S. PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 56 U.S. PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 57 U.S. PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 58 CANADA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 59 CANADA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 60 CANADA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 61 CANADA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 62 CANADA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 63 CANADA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 64 CANADA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 65 MEXICO PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 66 MEXICO PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 67 MEXICO PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 68 MEXICO PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 69 MEXICO PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 70 MEXICO PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 71 MEXICO PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 72 EUROPE PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 73 EUROPE PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 74 EUROPE PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 75 EUROPE PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 76 EUROPE PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 77 EUROPE PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 78 EUROPE PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 79 EUROPE PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 80 GERMANY PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 81 GERMANY PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 82 GERMANY PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 83 GERMANY PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 84 GERMANY PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 85 GERMANY PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 86 GERMANY PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 87 U.K. PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 88 U.K. PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 89 U.K. PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 90 U.K. PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 91 U.K. PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 92 U.K. PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 93 U.K. PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 94 FRANCE PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 95 FRANCE PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 96 FRANCE PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 97 FRANCE PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 98 FRANCE PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 99 FRANCE PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 100 FRANCE PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 101 ITALY PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 102 ITALY PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 103 ITALY PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 104 ITALY PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 105 ITALY PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 106 ITALY PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 107 ITALY PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 108 SPAIN PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 109 SPAIN PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 110 SPAIN PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 111 SPAIN PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 112 SPAIN PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 113 SPAIN PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 114 SPAIN PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 115 RUSSIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 116 RUSSIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 117 RUSSIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 118 RUSSIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 119 RUSSIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 120 RUSSIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 121 RUSSIA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 122 POLAND PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 123 POLAND PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 124 POLAND PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 125 POLAND PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 126 POLAND PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 127 POLAND PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 128 POLAND PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 129 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 130 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 131 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 132 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 133 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 134 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 135 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 136 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 137 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 138 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 139 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 140 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 141 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 142 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 143 HUNGARY PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 144 HUNGARY PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 145 HUNGARY PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 146 HUNGARY PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 147 HUNGARY PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 148 HUNGARY PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 149 HUNGARY PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 150 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 151 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 152 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 153 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 154 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 155 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 156 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 157 NORWAY PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 158 NORWAY PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 159 NORWAY PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 160 NORWAY PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 161 NORWAY PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 162 NORWAY PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 163 NORWAY PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 164 IRELAND PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 165 IRELAND PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 166 IRELAND PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 167 IRELAND PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 168 IRELAND PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 169 IRELAND PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 170 IRELAND PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 171 BELGIUM PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 172 BELGIUM PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 173 BELGIUM PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 174 BELGIUM PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 175 BELGIUM PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 176 BELGIUM PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 177 BELGIUM PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 178 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 179 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 180 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 181 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 182 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 183 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 184 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 185 REST OF EUROPE PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 186 ASIA-PACIFIC PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 187 ASIA-PACIFIC PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 188 ASIA-PACIFIC PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 189 ASIA-PACIFIC PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 190 ASIA-PACIFIC PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 191 ASIA-PACIFIC PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 192 ASIA-PACIFIC PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 193 ASIA-PACIFIC PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 194 INDIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 195 INDIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 196 INDIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 197 INDIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 198 INDIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 199 INDIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 200 INDIA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 201 AUSTRALIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 202 AUSTRALIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 203 AUSTRALIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 204 AUSTRALIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 205 AUSTRALIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 206 AUSTRALIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 207 AUSTRALIA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 208 SOUTH KOREA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 209 SOUTH KOREA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 210 SOUTH KOREA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 211 SOUTH KOREA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 212 SOUTH KOREA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 213 SOUTH KOREA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 214 SOUTH KOREA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 215 SINGAPORE PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 216 SINGAPORE PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 217 SINGAPORE PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 218 SINGAPORE PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 219 SINGAPORE PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 220 SINGAPORE PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 221 SINGAPORE PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 222 MALAYSIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 223 MALAYSIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 224 MALAYSIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 225 MALAYSIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 226 MALAYSIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 227 MALAYSIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 228 MALAYSIA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 229 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 230 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 231 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 232 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 233 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 234 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 235 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 236 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 237 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 238 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 239 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 240 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 241 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 242 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 243 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 244 ISRAEL PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 245 ISRAEL PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 246 ISRAEL PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 247 ISRAEL PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 248 ISRAEL PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 249 ISRAEL PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 250 ISRAEL PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 251 EGYPT PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 252 EGYPT PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 253 EGYPT PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 254 EGYPT PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 255 EGYPT PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 256 EGYPT PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 257 EGYPT PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 258 UAE PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 259 UAE PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 260 UAE PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 261 UAE PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 262 UAE PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 263 UAE PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 264 UAE PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 265 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 266 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 267 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 268 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 269 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 270 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 271 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 272 SOUTH AMERICA PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 273 SOUTH AMERICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 274 SOUTH AMERICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 275 SOUTH AMERICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 276 SOUTH AMERICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 277 SOUTH AMERICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 278 SOUTH AMERICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 279 SOUTH AMERICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 280 BRAZIL PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 281 BRAZIL PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 282 BRAZIL PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 283 BRAZIL PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 284 BRAZIL PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 285 BRAZIL PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 286 BRAZIL PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 287 ARGENTINA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 288 ARGENTINA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 289 ARGENTINA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 290 ARGENTINA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 291 ARGENTINA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 292 ARGENTINA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 293 ARGENTINA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 294 REST OF SOUTH AMERICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The Application Segment Psychedelic Drugs Market are Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Others
The major companies providing psychedelic drugs are Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.), Hikma Pharmaceuticals PLC, COMPASS, Verrian, Pfizer Inc., F. Hoffmann-La Roche Ltd, Jazz Pharmaceuticals, Inc., PharmaTher Inc., Avadel, Celon Pharma S.A., NeuroRx, Inc., usonainstitute.org among other domestic players.
The Psychedelic Drugs Market is to grow at a CAGR of 13.3% during the forecast by 2029.
The market value of the Psychedelic Drugs Market is expected USD 6,401.95 million by 2029.